Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Current Size And Growth Outlook For The Black Lung Disease Market?
The market size of black lung disease has experienced a swift augmentation in past years. Its anticipated growth through 2024 to 2025 is from $9.66 billion to $10.92 billion, marking a compound annual growth rate (CAGR) of 13.1%. This notable growth during the historic period can be accredited to the expansion of the coal mining industry, increased awareness and education, ameliorated compensation and benefits, and progressive legislative and legal developments.
In the coming years, the market size for black lung disease is slated for a swift expansion, projected to hit $19.23 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 15.2%. The growth anticipated during this forecast period can be attributed to a number of factors, including public health initiatives, medical advancements, expanding treatment options, as well as advocacy and supportive organizations. Key trends for this period include the adoption of advanced diagnostic methods, research and prevention efforts, healthcare accessibility, and technological progression.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12988&type=smp
What Core Drivers Are Expected To Influence The Black Lung Disease Market?
The upward surge in mining activities will likely fuel the expansion of the black lung disease market. Mining activities typically include extracting precious minerals, ores, and other geological material from the earth’s crust, which, when inhaled in the form of coal mine dust, causes black lung disease. This disease essentially affects coal miners as the dust contains harmful carbon-enriched particles. The International Energy Agency (IEA), an intergovernmental organization based in France, noted in July 2023 that production of critical minerals witnessed a noteworthy uptick, rising by 30% to hit $41 billion in 2022, followed by a 20% increase in 2021. The consumption of critical minerals over the past five years has magnified considerably, with a threefold rise in lithium usage and a 70% jump in cobalt requirements. Therefore, the rise in mining operations remains a significant driving force behind the growth of the black lung disease market.
Which Segmentation Categories Are Highlighted In The Black Lung Disease Market Analysis?
The black lung diseasemarket covered in this report is segmented –
1) By Type: Simple Coal Worker’s Pneumoconiosis; Complicated Coal Worker’s Pneumoconiosis; Other Types
2) By Treatment: Oxygen Therapy; Bronchodilators; Lung Transplant; Stem Cell Therapy; Other Treatment
3) By Diagnosis: Biopsy; Imaging; Full Blood Count; Pulmonary Or Lung Function Tests; Physical Examination; Other Diagnosis
4) By End Users: Hospitals And Clinics; Research Organizations And Academic Institutes; Diagnostic Centers And Labs; Other End Users
Subsegments:
1) By Simple Coal Worker’s Pneumoconiosis: Asymptomatic Simple Pneumoconiosis; Symptomatic Simple Pneumoconiosis
2) By Complicated Coal Worker’s Pneumoconiosis: Progressive Massive Fibrosis (PMF); Complicated Pneumoconiosis With Respiratory Symptoms
3) By Other Type: Mixed Dust Pneumoconiosis; Other Related Respiratory Diseases
Who Are The Dominant Players In The Black Lung Disease Market Today?
Major companies operating in the black lung disease market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric, F. Hoffmann-La Roche AG, Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Melinta Therapeutics LLC, GlaxoSmithKline PLC, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Toshiba Corporation, Koninklijke Philps N.V., Mayo Clinic, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Lab India Pvt. Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Lupin Limited.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report
Which Regional Markets Are Emerging As Key Hubs For The Black Lung Disease Market?
North America was the largest region in the black lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12988&type=smp
Browse Through More Reports Similar to the Global Black Lung Disease Market 2025, By The Business Research Company
Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025
Respiratory Disposables Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report
Respiratory Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model